Table 3.
Rotavirus VE for ≥1 and 2 doses in preventing hospitalization due to AGE and RVGE in vaccinated children compared to unvaccinated children from the pre-universal vaccination period.
| Hospitalized | Total | Proportion (%) | Crude VE [95% CI], % | Adjusted VEa [95% CI], % | |
|---|---|---|---|---|---|
| ≥1 dose | |||||
| AGE | |||||
| Vaccinated | 28 | 5,033 | 0.56 | ||
| Unvaccinated | 87 | 6,436 | 1.35 | 59 [37 to 73] | 58 [35 to 72] |
| RVGE | |||||
| Vaccinated | 2 | 5,033 | 0.04 | ||
| Unvaccinated | 24 | 6,436 | 0.37 | 89 [55 to 98] | NAb |
| 2 doses | |||||
| AGE | |||||
| Vaccinated | 20 | 4,767 | 0.42 | ||
| Unvaccinated | 73 | 6,436 | 1.13 | 63 [40 to 78] | 62 [37 to 77] |
| RVGE | |||||
| Vaccinated | 1 | 4,767 | 0.02 | ||
| Unvaccinated | 21 | 6,436 | 0.33 | 94 [52 to 99] | NAb |
a
Adjusted for sex, maternal age at birth, prematurity and age at the end of the study in months.
b
Multivariate analyses could not be performed because of the small number of cases in post-program period.
NA indicates non applicable.